Radnet Inc 's Cash & cash equivalent grew by 56.01 % in the Q2 2026 sequentially, faster than Current Liabilities, this led to improvement in Radnet Inc 's Quick Ratio to 1.11, above Radnet Inc average Quick Ratio.

Within Medical Laboratories industry 20 other companies have achieved higher Quick Ratio than Radnet Inc in second quarter 2026. While Quick Ratio total ranking has improved so far during the Q2 2026 to 1721, from total ranking in the first quarter 2026 at 1784.

Explain Quick Ratio?
How much Cash & cash equivalents RDNT�s has?
What are RDNT�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

RDNT Quick Ratio	(Jun 30 2026) Q2	(Mar 31 2026) Q1	(Dec 31 2025) Q4	(Sep 30 2025) Q3	(Jun 30 2025) Q2
Y / Y Current Liabilities Change	27.76 %	25.77 %	21.55 %	22.29 %	15.19 %
Y / Y Cash & cash equivalent Change	-11.69 %	-34.21 %	4.25 %	6.74 %	10.45 %
Quick Ratio MRQ	1.11	0.78	1.38	1.47	1.6
RDNT's Total Ranking	# 1721	# 1784	# 876	# 1190	# 1102
Seq. Current Liabilities Change	9.78 %	8.33 %	2.06 %	5.26 %	8.08 %
Seq. Cash & cash equivalent Change	56.01 %	-38.6 %	-4.74 %	-3.22 %	16.24 %

Quick Ratio second quarter 2026 Company Ranking
Within:	No.
Medical Laboratories Industry	# 21
Healthcare Sector	# 609
Overall Market	# 1721

Quick Ratio Statistics
High	Average	Low
1.69	0.44	0.03
(Sep 30 2024)		(Jun 30 2012)

Financial Statements
Radnet Inc 's Current Liabilities	$ 698 Millions	Visit RDNT's Balance sheet
Radnet Inc 's Cash & cash equivalent	$ 774 Millions	Visit RDNT's Balance sheet
Source of RDNT's Sales		Visit RDNT's Sales by Geography

Cumulative Radnet Inc 's Quick Ratio

RDNT's Quick Ratio for the trailling 12 Months

RDNT Quick Ratio	(Jun 30 2026) 12 Months	(Mar 31 2026) 12 Months	(Dec 31 2025) 12 Months	(Sep 30 2025) 12 Months	(Jun 30 2025) 12 Months
Y / Y Current Liabilities TTM Growth	24.48 %	21.27 %	19.32 %	13.38 %	11.53 %
Y / Y Cash & cash equivalent TTM Growth	-8.56 %	-2.84 %	11.64 %	27.19 %	48.43 %
Quick Ratio TTM	1.17	1.29	1.48	1.54	1.6
Total Ranking TTM	# 3989	# 3942	# 2913	# 3150	# 2970
Seq. Current Liabilities TTM Growth	6.47 %	5.88 %	4.93 %	5.23 %	3.73 %
Seq. Cash & cash equivalent TTM Growth	-3.38 %	-7.85 %	1.01 %	1.67 %	2.66 %

Quick ratio ranking by company, industry and sector >> Back to RDNT Financial Strength Comparisons >> Go to Compare RDNT Quick Ratio to its Competitors

On the trailing twelve months basis Due to rise in Current Liabilities in the Q2 2026 to $697.82 millions, cumulative Quick Ratio decreased to 1.17 above the RDNT average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Laboratories industry 36 other companies have achieved higher Quick Ratio than Radnet Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2026 from 3942 to 3989.

Explain Quick Ratio?
How much Cash & cash equivalents RDNT�s has?
What are RDNT�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Medical Laboratories Industry	# 37
Healthcare Sector	# 895
Within the Market	# 3989

trailing twelve months Quick Ratio Statistics
High	Average	Low
1.61	0.42	0.03
(Mar 31 2025)		(Mar 31 2015)

Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Medical Laboratories Industry	Quick Ratio	Jun 30 2026 MRQ Cash & cash equivalent	Jun 30 2026 MRQ Current Liabilities
Butterfly Network Inc	2.13	$ 124.659 Millions	$ 58.603 Millions
Natera Inc	1.97	$ 1,091.502 Millions	$ 553.200 Millions
Biodesix Inc	1.96	$ 29.996 Millions	$ 15.291 Millions
Sera Prognostics Inc	1.91	$ 46.445 Millions	$ 24.356 Millions
Exagen Inc	1.83	$ 24.588 Millions	$ 13.457 Millions
Radnet Inc	1.11	$ 773.510 Millions	$ 697.822 Millions
Bioaffinity Technologies Inc	0.91	$ 2.430 Millions	$ 2.681 Millions
Ispecimen inc	0.43	$ 4.426 Millions	$ 10.196 Millions
Quest Diagnostics Inc	0.40	$ 720.000 Millions	$ 1,788.000 Millions
Lumexa Imaging Holdings Inc	0.39	$ 69.705 Millions	$ 178.355 Millions
Medpace Holdings Inc	0.35	$ 502.688 Millions	$ 1,435.429 Millions
American Shared Hospital Services	0.30	$ 6.761 Millions	$ 22.424 Millions
Nuo Therapeutics, Inc.	0.29	$ 0.449 Millions	$ 1.554 Millions
Icon Plc	0.24	$ 930.885 Millions	$ 3,934.665 Millions

Date modified: 2026-08-12T20:45:56+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.